Korean pharmaceutical and biotechnology companies are set to present their latest studies at the American Association for Cancer Research (AACR) Annual Meeting 2024.The AACR meeting, established in 1907 and regarded as one of the world's top three cancer conferences alongside those of the American S
The National Cancer Center (NCC) said it has discovered a biomarker that can distinguish pancreatic cancer patients from healthy individuals "with 100 percent accuracy" and has licensed out the biomarker to New Cancer Cure Bio.The biomarkers X-100 and X-99 have shown the capability to accurately dif
ST Pharm and LegoChem Biosciences have entered into a contract for joint research and manufacturing of antibody drug conjugate (ADC) linkers.Under the accord, ST Pharm plans to provide contract development and manufacturing organization (CDMO) services covering the entire production process based on
Celltrion said it has completed its application to the U.S. FDA for the approval of CT-P39, a biosimilar referencing Xolair (ingredient: omalizumab). Xolair was developed by Genentech and Novartis for the treatment of allergic asthma, chronic rhinosinusitis with nasal polyposis, and chronic idiopath
Olympus, a Japan-based global medical device company, has decided to terminate its acquisition of Taewoong Medical, a Korea-based specialist in gastrointestinal stents, just two months after announcing the deal in January.The decision comes after Olympus discovered issues related to data integrity i
A research team -- led by Professor Kim Beom-joon of the Neurology Department at Seoul National University Bundang Hospital (SNUBH), together with Professor Kang Dong-Wan from the Neurology Department of the Gyeonggi Provincial Medical Center Icheon Hospital -- has received the "2024 Paul Dudley Whi
In a groundbreaking effort to combat cardiovascular diseases (CVDs) in Asia-Pacific, the Asia-Pacific Cardiovascular Disease Alliance recently released the "A Call for Cohesive Action: Redefining Cardiovascular Care Report," which underscored the region's unique position and ongoing efforts to curb
In response to a mass resignation of trainee physicians that has led to significant medical disruptions, the Korean government said it would spend 200 billion won ($150.1 million) per month into the healthcare system to maintain emergency and patient care.The Ministry of Health and Welfare on Thursd
In a significant milestone marking the ten-year collaboration between SK bioscience and Sanofi, a global leader in healthcare, the two companies have embarked on an ambitious expansion of the L HOUSE, SK bioscience’s vaccine manufacturing plant in Andong, North Gyeongsang Province.This expansion aim
Curocell, a Kosdaq-listed biotech company, said it received the topline data from its phase 2 clinical trial for its CAR-T (chimeric antigen receptor-T) therapy, Anbal-cel, to treat diffuse large B-cell lymphoma (DLBCL).The study is Korea's first clinical trial of a CAR-T therapy, involving 79 adult
Seoul National University Bundang Hospital (SNUBH) has spearheaded the launch of a network aimed at timely treatment of severe and emergency cardiocerebrovascular diseases, such as stroke and myocardial infarction, within Gyeonggi Province.This initiative, part of the Ministry of Health and Welfare'
Bridge Biotherapeutics has reported a significant downturn in its financial performance for the year 2023.The company's annual revenue plummeted to 100 million won ($74,878), marking a drastic 96.7 percent decrease compared to the previous year.This downturn is attributed to the absence of additiona
In a recent statement titled "Weight Management and CGM," the Korean Society for the Study of Obesity (KSSO) has voiced concerns over the unverified use of continuous glucose monitoring (CGM) devices for weight loss in individuals without diabetes.Such concerns come amid companies like Dr.Diary intr
The Korean medical device sector showcased its latest technologies and research achievements at the European Congress of Radiology 2024 (ECR 2024), held from Feb. 28 to last Suday in Vienna, Austria. ECR is recognized as one of the world's largest conferences in the field of radiology, alongside the
Binex, a Kosdaq-listed biopharmaceutical CDMO, has been subjected to a two-month suspension of sales operations for Bimo 5mg (ingredient: minoxidil), a hair loss treatment, for failing to submit necessary documents for the 2023 drug equivalence reevaluation.The product in question will not be availa
The Korean medical community is facing an unprecedented crisis as tensions escalate between the government and healthcare professionals over the proposed increase in medical school admissions by 2,000 in 2025.The dispute has broadened from trainee doctors to encompass the entire medical sector, with
i-SENS, a Kosdaq-listed biotech company, said it received product approval for CareSens Air, its continuous glucose monitoring (CGM) device, from the European Conformité Européenne (CE) Medical Device Regulation (MDR) last Thursday.The CareSens Air CGM system offers a non-invasive solution for diabe
Samjin Pharmaceutical announced a strategic investment of 1 billion won ($751,371) in Neurophet, a company specializing in AI solutions for brain disorder imaging, to fight dementia and stroke.Under the accord, the two companies seek to leverage Samjin’s extensive research resources, infrastructure,
Hugel said it received approval from the U.S. FDA for its botulinum toxin product, Letybo, in 50-unit and 100-unit dosages.This FDA approval marks a significant development for Hugel, following its third attempt to gain approval for Letybo.The company's journey to this point involved addressing feed
Celltrion said it reported consolidated sales of 2.1 trillion won ($1.5 billion) and operating income of 651 billion won in 2023, down 4.71 percent and up 0.66 percent, respectively, from the previous year.The company also posted a net profit of 539.2 billion won, down 0.53 percent, and an operating